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Abstract: We have previously addressed that fructose rich diet (FRD) intake for three weeks increases
the adipogenic potential of stromal vascular fraction cells from the retroperitoneal adipose tissue
(RPAT). We have now evaluated the effect of prolonged FRD intake (eight weeks) on metabolic
parameters, number of adipocyte precursor cells (APCs) and in vitro adipogenic potential from
control (CTR) and FRD adult male rats. Additionally, we have examined the direct fructose effects
on the adipogenic capacity of normal APCs. FRD fed rats had increased plasma levels of insulin,
triglyceride and leptin, and RPAT mass and adipocyte size. FACS studies showed higher APCs
number and adipogenic potential in FRD RPAT pads; data is supported by high mRNA levels
of competency markers: PPARγ2 and Zfp423. Complementary in vitro experiments indicate that
fructose-exposed normal APCs displayed an overall increased adipogenic capacity. We conclude that
the RPAT mass expansion observed in eight week-FRD fed rats depends on combined accelerated
adipogenesis and adipocyte hypertrophy, partially due to a direct effect of fructose on APCs.
Keywords: retroperitoneal adipose tissue; adipogenesis; SVF cells; precursor cell competency
1. Introduction
In the last few decades, obesity, metabolic syndrome and type 2 diabetes mellitus (DMT2) have
become serious problems for health systems, emerging as a worldwide epidemic. These metabolic
disorders are multifactorial depending on genetic background as well as environmental and behavioral
factors, such as eating habits. The quantity and quality of modern diets, in particular the increase of
sugar intake, have been associated with the high incidence of metabolic disorders [1,2]. In fact, high
fructose consumption, mainly through sweetened drinks, has been linked to deleterious metabolic
consequences, such as insulin resistance, dyslipidemias, increased abdominal adipose tissue (AAT)
mass and changes in the pattern of AT adipokine secretion [3,4].
The deleterious metabolic effects of high fructose intake have been related to the activating role
in the de novo lipogenesis pathway in the liver, and therefore stimulating AT fatty acid uptake. This
stimulation of de novo lipogenesis is not so markedly increased by other carbohydrates [5], mainly
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because fructose bypasses the main control point of glycolysis, the phosphofructokinase step, and
is converted into trioses [6], precursors of triglyceride synthesis. Although most of the absorbed
fructose is extracted and metabolized by the liver [7], a small amount remains in circulation and can be
absorbed through its specific cellular transporter GLUT-5 by tissues such as kidney and AT [8,9].
The increase in AAT mass has been considered one of the main disorders associated with
fructose overconsumption. AT expansion is the result of two independent processes: hyperplasia
and hypertrophy. Dysfunctional AT is correlated with adipocyte size rather than AT mass. In fact,
hypertrophic adipocytes are insulin resistant; secrete more leptin and pro-inflammatory cytokines
and less adiponectin [10–12]. AT hyperplasia is the consequence of activated adipogenesis; a process
involving two stages: the determination of the adipocyte precursor cells (APCs) and terminal cell
differentiation, wherein APCs change into adipocytes. The ability of APCs to turn into adipocytes after
specific stimulation is known as APCs competency and it is a characteristic of determined cells [13].
As we have previously shown, fructose rich diet (10% w/v, FRD) intake induces several metabolic
alterations related to AT mass expansion [14–16]; however the activation or inhibition of adipogenesis
in this phenomenon remains unclear. In the 3T3L1 preadipocyte cell line, the addition of fructose to
the culture medium stimulates the terminal stage of adipogenesis, a mechanism that is dependent on
the specific fructose transporter, GLUT-5 [17,18]. We earlier demonstrated that adult rats fed with FRD
for three weeks showed APCs from retroperitoneal AT (RPAT) displaying high levels of competency
markers, such as PPARγ2 and Zfp423 [15]. Nevertheless, the in vivo impact of FRD intake for a longer
period of time and the direct in vitro effect of fructose on APCs adipogenic potential and number have
not been studied up to now. Our study provides, for the first time, evidence that high fructose intake
for eight weeks increases, probably through a direct effect, the number and competency of APCs from
RPAT, therefore favoring adipocyte differentiation and contributing to its mass expansion.
2. Material and Methods
2.1. Animals and Treatment
Normal adult male Sprague-Dawley rats (60 days of age) were kept in a temperature-controlled
environment (20–22 ˝C and fixed 12 h light/12 h dark cycle, lights on at 07:00 a.m. and fed ad libitum
with Purina commercial rat chow. Rats were divided into two groups: one was provided with
tap water only (CTR) and, the other, a solution of 10% fructose (w/v, Sigma-Aldrich, St. Louis,
MO, USA) in tap water for eight weeks (conventionally called fructose rich diet, FRD). Rats were
euthanized under non-fasting conditions (between 08:00 a.m. and 09:00 a.m.) and trunk blood was
collected; plasma samples were then frozen (´20 ˝C) until metabolite measurements were taken. RPAT
was aseptically dissected (brown adipose tissue vessels surrounding the kidney were removed and
discarded), weighed and kept in sterile Dulbecco’s Modified Eagle’s Medium-Low Glucose (1 g/L)
(DMEM-LG) for further procedures. Animals were euthanized according to protocols for animal use,
in agreement with NIH guidelines for the care and use of experimental animals. All experiments were
approved by our Institutional Animal Care Committee.
2.2. Peripheral Metabolite Measurements
Plasma levels of leptin (LEP), insulin (INS) and corticosterone (CORT) were determined by
specific radioimmunoassays (RIAs) previously developed in our laboratory [19]. Circulating glucose
(Glu, Wiener Argentina Lab., Rosario, Argentina) and triacylglycerols (Tg, Wiener, Rosario, Argentina)
levels were measured using commercial kits.
2.3. RPAT Stromal Vascular Fraction (SVF) Cell and Adipocyte Isolation
Fresh RPAT pads were dissected, weighed and digested with collagenase as previously
reported [20]. Briefly, fat tissue was minced and digested using 1 mg/mL collagenase solution in
DMEM (at 37 ˝C, for 1 h). After centrifugation (1000 rpm, during 15 min), floating mature adipocytes
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were separated and reserved for later measurement. SVF pellets were filtered (in a 50 µm mesh nylon
cloth) and washed with DMEM-LG (ˆ3). SVF cells, containing APCs, were then resuspended in
DMEM-LG supplemented with 10% (v/v) fetal bovine serum (FBS), HEPES (20 nM), 100 IU/mL
penicillin and 100 µg/mL streptomycin (basal medium).
2.4. Adipocyte Size Analysis
The size of the isolated fat cells was measured as previously described [21], with minor changes.
Briefly, a 50–150 µL aliquot from the top layer (floating cells) was added to 450 µL DMEM. 5–10 µL
from the cell suspension were placed into a Neubauer chamber and cover-slipped. Five representative
pictures from each sample were taken using a Nikon Eclipse 50i microscope equipped with a camera
(Nikon Digital Sight D5-U3, Melville, NY, USA). Cell diameter was measured with image analysis
software (Image ProPlus6.0, Rockville, MD, USA). Values below 25 µm were discarded as they can be
considered lipid droplets. Values were recorded and assigned to groups differing by 10 µm diameter,
creating a histogram with 10 µm-bins. Histograms were used to determine whether the distribution
of adipocyte diameters was either normal or binomial, and to assess the presence of different sized,
adipocyte sub-populations. We measured an average of 500–600 cells per field to calculate average
adipocyte size.
2.5. RPAT SVF Cell Culture
RPAT SVF cells from CTR and FRD groups were seeded (2 ˆ 104 cells/cm2) in 24-well plates
(Greiner Bio-One, Kremsmünster, Austria) and cultured in the basal medium at 37 ˝C in a 5%
CO2-atmosphere [20]. Cells were induced to differentiate and processed for several determinations
as described in more detail below (Materials and Methods section: 2.8; 2.9; 2.10; 2.11). Additionally,
normal SVF cells from RPAT from control adult male rats were seeded and cultured for 7 days in
the basal medium alone (Basal) or supplemented with 1 g/L of fructose (FRU) or 1 g/L glucose
(GLU). After this period cells were immediately processed for RNA extraction or FACS analysis,
or differentiated to adipocytes for lipid content determination, as described below.
2.6. SVF Cell Composition Analysis by Flow Cytometry (FACS)
Freshly isolated or cultured SVF cells from RPAT pads (at least 2 ˆ 105 cells in 100 µL PBS/0.5%
BSA) were incubated with fluorescent antibodies or respective isotype controls for 1 h at 4 ˝C. After
washing steps, flow cytometry was performed using a FACSCalibur flow cytometer (Becton Dickinson
Biosciences, San Jose, CA, USA). A combination of cell surface markers were used to identify APCs as:
CD34+/CD45´/CD31´ for freshly isolated SVF cells and CD34+/CD31´ for cultured SVF cells [22].
Conjugated monoclonal antibodies used were: anti-rat CD34:PE, anti-rat CD45:FITC, and anti-rat
CD31:FITC (1 µg/1 ˆ 106 cells, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). Samples were
analyzed using CellQuest Pro (Becton-Dickinson, San Jose, CA, USA) and FlowJo softwares (TreeStar,
San Carlo, CA, USA).
2.7. Cell Differentiation
Proliferating SVF cells (having reached 70%–80% confluence after 5–6 days of culture) were
induced to differentiate by the addition of a differentiation mix containing 5 µg/mL insulin,
0.25 µM DXM, 0.5 mM 3-isobutyl-L-methylxanthine (IBMX) in the basal medium [20]. After 48 h
media were removed and replaced with the fresh basal medium containing 5 µg/mL insulin. Cell
samples were harvested after 10 days of the induction of differentiation (Dd10) and processed for
several determinations, as described below. Medium samples were taken on Dd10 and kept frozen at
´20 ˝C until measurement of leptin concentrations (see below).
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2.8. RNA Isolation and Quantitative Real-Time PCR (qRT-PCR)
Total RNA was isolated from cells by the Trizol extraction method (Invitrogen, Life Tech., Carlsbad,
CA, USA). Total RNA was reverse-transcribed using random primers (250 ng) and RevertAid Reverse
Transcriptase (200 U/µL, Thermo Scientific, Vilnius, Lithuania). Two µL cDNA were amplified
with HOT FIRE Pol EvaGreenqPCR Mix Plus (Solis BioDyne, Tartu, Estonia) containing 0.5 µM of
each specific primer, using LightCycler Detection System (MJ Mini Opticon, Biorad, CA, USA). PCR
efficiency was near 1. Expression levels were analyzed for β-actin (ACTβ, reporter gene), Adiponectin
(ADIPOQ), CCAAT/enhancer binding protein alpha (C/EBPα), glucose transporter (GLUT-4), fructose
transporter (GLUT-5) glucocorticoid receptor (GR), insulin receptor 1 (IRS-1) and 2 (IRS-2), Leptin (Ob),
mineralocorticoid receptor (MR), Peroxisome Proliferator-Activated Receptor gamma 2 (PPAR-γ2),
Preadipocyte Factor 1 (Pref-1), wingless-type MMTV integration site family member 10b (WNT-10b)
and Zinc finger protein 423 (Zfp423). Designed primers are shown in alphabetical order in Table 1.
Relative changes in the expression level of one specific gene (∆∆Ct) were calculated by the ∆Ct method.
Table 1. Rat specific primers for qRT-PCR.
Primers (51-31) GBAN bp
ACTβ
se, AGCCATGTACGTAGCCATCC
NM_031144 115as, ACCCTCATAGATGGGCACAG
ADIPOQ
se, AATCCTGCCCAGTCATGAAG
NM_144744 159as, TCTCCAGGAGTGCCATCTCT
C/EBPα
se, CTGCGAGCACGAGACGTCTATAG
NM_012524 159as, TCCCGGGTAGTCAAAGTCACC
GLUT-4
se, GCTTCTGTTGCCCTTCTGTC
NM_012751.1 166as, TGGACGCTCTCTTTCCAACT
GLUT-5
se, CTTGCAGAGCAACGATGGAG
NM_031741.1 145as, AACTCTGAGGGCGAGTTGAC
GR
se, TGCCCAGCATGCCGCTATCG
NW_047512 170as, GGGGTGAGCTGTGGTAATGCTGC
IRS-1
se, TGTGCCAAGCAACAAGAAAG
NM_012969.1 176as, ACGGTTTCAGAGCAGAGGAA
IRS-2
se, CTACCCACTGAGCCCAAGAG
NM_001168633.1 151as, CCAGGGATGAAGCAGGACTA
MR
se, TCGCTCCGACCAAGGAGCCA
NM_013131 193as, TTCGCTGCCAGGCGGTTGAG
Ob
se, GAGACCTCCTCCATCTGCTG
NM_013076 192as, CTCAGCATTCAGGGCTAAGG
PPAR-γ2
se, AGGGGCCTGGACCTCTGCTG
NW_047696 185as, TCCGAAGTTGGTGGGCCAGA
Pref-1
se, TGCTCCTGCTGGCTTTCGGC
NM_053744 113as, CCAGCCAGGCTCACACCTGC
Wnt-10b
se, AGGGGCTGCACATCGCCGTTC
NW_047784 175as, ACTGCGTGCATGACACCAGCAG
Zfp423 se, CCGCGATCGGTGAAAGTTG NM_053583.2 121as, CACGGCTGGATTTCCGATCA
Primers sequences are listed in alphabetical order (se: sense; as: anti-sense; GBAN: GenBank Accession Number;
bp: amplicon length in bp).
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2.9. Leptin Measurement
Medium leptin concentration was determined by specific RIA [23]. In this assay, the standard
curve ranged between 50 and 12,500 pg/mL, coefficients of variation intra- and inter-assay of 4%–7%
and 9%–11%, respectively.
2.10. Cellular Lipid Content
On Dd 10, cells were washed with PBS and fixed with 10% formalin (for 10–15 min) in PBS. Then
cells were quickly washed with PBS and stained for 1 h with Oil-Red O (ORO) solution (2:3 v/v
H2O:isopropanol, containing 0.5% ORO) [24]. After staining, cells were washed (ˆ3 with PBS) and
dye from lipid droplets was extracted by adding isopropanol (10 min). To quantify cell lipid content,
sample OD was obtained at 510 nm in a spectrophotometer. Remaining cells were digested with
0.25% Trypsin solution in PBS-EDTA, at 37 ˝C for 24 h and centrifuged at 8000ˆ g for 15 s. OD of
supernatants was read at 260 nm for DNA quantification and cell lipid content (measured by ORO and
expressed in OD units) was then expressed by the corresponding cell DNA content.
2.11. Percentages of Cell Differentiation and Maturation
On Dd 10, differentiated cells were fixed with 10% formalin solution for 1 h at room temperature,
and then stained using the Papanicolaou technique. The percentage of differentiated cells was
calculated by counting the total number of cells and that of cells containing lipid droplets, when
visualized in a light microscope (after counting 200–250 total cells per layer, at 40ˆ magnification).
Lipid-containing cells were assigned to one of the 3 graded stages of maturation according to the
nucleus position: stage I (central), stage II (between central and peripheral), and stage III (completely
peripheral) [25]. Percentages of cells corresponding to each maturation stage were expressed in relation
to the total number of differentiated cells. Image analysis was assessed using a light Nikon Microscope
and image analysis software (Image ProPlus6.0, Rockville, MD, USA).
2.12. Statistical Analysis
Results are expressed as mean values ˘ SEM. Data were analyzed by ANOVA (one-way) followed
by Fisher’s test. To determine the differential effect of the treatment according to age, ANOVA
(two-ways) was performed followed by Bonferroni’s test. The non-parametric Mann-Whitney test
was used to compare adipocyte size populations between groups. Normal or binomial distribution of
adipocyte size data was determined by Kruskall-Wallis test, followed by Mann-Whitney test. P values
lower than 0.05 were considered statistically significant. All statistical tests were performed using
GraphPad Prism 6.0.
3. Results
3.1. Effect of FRD Intake on Metabolic Parameters
FRD rats showed high average of total energy intake from three up to eight weeks of treatment
(Figure 1A), although they did not exhibit differences in body weight (Figure 1B). However, FRD
intake significantly increased INS, Tg and LEP plasma levels, and also induced a significant increase in
RPAT depot (Table 2). When we determined the size distribution of mature adipocytes contained in
the RPAT we found two adipocyte populations, one similar to and another larger than CTR adipocyte
population (Figure 2). The presence of small adipocytes in FRD rats may suggest that the generation of
new adipocytes took place (adipogenesis), whereas large adipocytes could be the result of enlargement
of preexisting fat cells, leading to adipocyte hypertrophy.
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Table 2. Metabolic parameters in CTR and FRD rats. 
 CTR FRD 
Body Weight (g) 403.87 ± 10.54 408.69 ± 10.95 
LEP (ng/mL) 5.34 ± 0.68 9.39 ± 1.66 * 
CORT (nM) 345.21 ± 32.32 282.67 ± 23.36 
INS (nM) 0.29 ± 0.04 0.46 ± 0.03 * 
Glu (mM) 6.94 ± 0.11 7.05 ± 0.22 
Tg (mM) 1.29 ± 0.09 2.51 ± 0.16 * 
RPAT mass (g) 3.92 ± 0.29 5.30 ± 0.51 * 
RPAT Adipocyte diameter (μm) 69.24 ± 0.67 77.36 ± 0.77 * 
Body weight, plasma levels of several metabolites, AT mass and adipocyte size from RPAT in CTR 
and FRD rats. Values are means ± SEM (n = 8 rats per group). * p < 0.05 vs. CTR values. 
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Figure 1. Food-derived energy intake and body weight of CTR and FRD rats. (A) Caloric intake and
(B) body weight of CTR and FRD rats. Values are means ˘ SEM (n = 8 rats per group). * p < 0.05 vs.
CTR values on the same day.
Table 2. Metabolic parameters in CTR and FRD rats.
CTR FRD
Body Weight (g) 403.87 ˘ 10.54 408.69 ˘ 10.95
LEP (ng/mL) 5.34 ˘ 0.68 9.39 ˘ 1.66 *
CORT (nM) 345.21 ˘ 32.32 282.67 ˘ 23.36
INS (nM) 0.29 ˘ 0.04 0.46 ˘ 0.03 *
Glu (mM) 6.94 ˘ 0.11 7.05 ˘ 0.22
Tg (mM) 1.29 ˘ 0.09 2.51 ˘ 0.16 *
RPAT mass (g) 3.92 ˘ 0.29 5.30 ˘ 0.51 *
RP T Adipocyte diameter (µm) 69.24 ˘ 0.67 77.36 ˘ 0.77 *
Body weight, plasma lev ls of several metabolites, AT mass and adipocyte size from RPAT in CTR and FRD rats.
Values are means ˘ SEM (n = 8 rats per group). * p < 0.05 vs. CTR values.
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Figure 2. RPAT adipocyte diameter distribution. Dotted and continuous lines represent FRD small
and large populations of adipocytes, respectively. Values are means ˘ SEM (n = 3 animals per group).
Representative images of CTR and FRD mature adipocytes in cell suspension are shown (right,
magnification 10ˆ). Scale bars at 200 µm.
3.2. FRD Modifies APCs Number and Adipogenic Potential
To test the effect of FRD intake on the adipogenic capacity of APCs, we measured the mRNA
levels of anti-adipogenic, pro-adipoge ic and competency factors expressed by these cells contained in
the SVF. Freshly isolated SVF cells from FRD pads expressed significantly (p < 0.05 vs. CTR cells) higher
levels of Zfp423 and PPARγ2 (competency markers), and the pro-adipogenic factor MR (Figure 3A).
Conversely, no differences were found in Pref-1 and Wnt-10b mRNA levels (anti-adipogenic factors,
i re 3 ).
We also evaluated the expression levels of the specific fructose transporter GLUT-5 in APCs.
We found that this gene was expressed in APCs, although no differences were noticed in either group
f cells; the same phenomenon occurred when GLUT-4 mRNA expression was quantified. Imp rtantly,
the APCs expression levels f GLUT-4 were markedly lower than those of GLUT-5, regardless of the
cell-group examined (Figure 3B).
Interestingly, the number of APCs contained in the SVF of RPAT pads, was significantly higher in
the FRD rats (Figure 3C). Collectively, these results strongly reveal that high fructose intake affects the
adipogenic potential of AP s, changing t eir ability to respond to the differentiation stimuli and their
c ll numb r.
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(GR and MR) markers. * p < 0.05 vs. CTR values; (B) Gene expression levels of the specific fructose
(GLUT-5) and glucose (GLUT-4) transporters in SVF cells in RPAT from CTR and FRD rats. Relative
values to GLUT-5 expression in CTR cells. (AU: arbitrary units). Values are means ˘ SEM (n = 4
different experiments). * p < 0.05 vs. GLUT-5 values from each group; (C) APCs number in SVF in
RPAT from CTR and FRD rats. APCs were identified by FACS analysis using CD34+CD45´CD31´
profile (indicated in red borders). Fluorescence profiles obtained for IgG isotype controls are shown in
Figure S1 (Supplementary materials) FITC: fluorescein isothiocyanate; PE: phycoerythrin. Values are
means ˘ SEM (n = 3/4 different experiments).
3.3. In vitro Adipocyte Differentiation
We measured two classical differentiation parameters, such as leptin release and intracellular
lipid content in order to determine whether the impact of FRD on APCs adipogenic potential affected,
in turn, terminal adipocyte differentiation. We found that while intracellular lipid content increased on
Dd 10 (Figure 4A) in FRD cells, leptin release was not modified (Figure 4B). Additionally, the mRNA
levels of fully differentiated adipocyte markers indicate that the expression levels of C/EBPα, IRS-1,
IRS-2, and Ob genes were higher in FRD than in CTR cells (Figure 4C).
Finally, we evaluated the percentage of differentiated cells and maturation degrees to determine
the extent of adipogenesis. Interestingly, we noticed a higher percentage of differentiated adipocytes
in RPAT from FRD, whereas the maturation degree in both groups remained the same (Figure 4E,F).
These results strongly support that higher APCs competency and number, described above, caused the
differentiation increase recorded in FRD adipocytes.
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3.4. Direct Effect of Fructose Exposure on the Adipogenic Potential of Normal APCs
To examine whether the effect of FRD on normal RPAT APCs was caused, at least in part, by a
direct cell exposure to fructose, cells were cultured with FRU and then the APCs adipogenic potential
was determined. Our results indicate that normal cells exposed to either FRU or GLU expressed
higher levels (vs. basal levels) of PPARγ2, without any change in those of Zfp423 (Figure 5A). We also
evaluated the mRNA expression level of GLUT-5, which was similarly expressed regardless of the
culture conditions, i.e., basal, FRU or GLU (Figure 5B). Similarly to that found in SVF cells (see above),
the mRNA expression of GLUT-4 was markedly lower than that of GLUT-5, regardless of FRU or
GLU condition. Again, APCs GLUT-4 mRNA levels were similar in all incubation conditions studied
(Figure 5B). Interestingly, MR expression level was higher only in FRU-exposed cells, whereas GR
expression levels were lower in both FRU- and GLU-exposed cells (Figure 5B).Nutrients 2016, 8, 198 11 of 16 
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Additionally we quantified the number of APCs after either FRU or GLU condition. Interestingly,
we found that APCs number increased in FRU- but not in GLU-exposed cells (Figure 5C), similarly
to what we observed in APCs from FRD-fed rats. It is important to highlight that after seven days
of culture, the presence of immune cells was undetectable (Figure S2, Supplementary Materials),
and for that reason CD45 was not used in the FACS analysis. Finally, in order to assess whether
these APCs changes might increase adipocyte differentiation, we analyzed the in vitro intracellular
lipid accumulation on Dd 10. We found that FRU-exposed, but not GLU-exposed, cells showed a
significantly higher lipid accumulation than that found in cells cultured in basal condition (Figure 5D).
Taken together, these results strongly suggest that a direct effect of fructose on the adipogenic potential
of APCs might be responsible, at least in part, for the subsequent increase in adipocyte differentiation.
4. Discussion
High-fructose feeding has been widely used in animal models to induce similar dysfunctions to
those seen in human obesity and metabolic syndrome phenotypes. We previously used FRD intake in
rats (10% p/v fructose in drinking water for three weeks) and found numerous metabolic disorders,
including peripheral insulin resistance, AAT adipocyte hypertrophy and high oxidative stress, and
others [14,15,26]. In the present study the rats were fed a FRD for eight weeks, which was only
hyper-caloric during the last five weeks of the experiment. The switch from iso- to hyper-caloric intake
could be the result of modifications in the peripheral hormone levels (e.g., ghrelin, leptin and peptide
YY (PYY)) and hypothalamic factors (e.g., neuropeptide Y (NPY), pro-opiomelanocortin (POMC))
involved in appetite control, leading to an increase in the caloric intake. It has been suggested that the
time required for the establishment of these changes in appetite regulation depends on the amount of
fructose ingested [27,28]. Similarly to our previous studies [14,15,26], eight-week FRD intake induced
several alterations, including increased plasma levels of INS, LEP and Tg.
The impact of FRD on the development of abdominal obesity has been studied in rodents and
humans [15,29]. We have now observed that eight-week FRD intake contributes to abdominal obesity
by increasing the RPAT, one of the most representatives AT depots in the rat abdominal cavity. AT depot
remodeling after fructose feeding has been reported in a previous study describing larger abdominal
adipocytes in contrast to smaller subcutaneous ones [30]. Our results agree with those findings; indeed,
adipocyte size analyses from RPAT showed that FRD adipocytes were hypertrophic compared to CTR
adipocytes. Besides, adipocyte size distribution showed two adipocyte populations in RPAT from
FRD rats: one similar and other larger than CTR adipocyte population, respectively, thus suggesting
that RPAT mass expansion in FRD rats may occur from both the combination of newly generated
adipocytes through adipogenesis and the hypertrophy of existing adipocytes, respectively.
It is accepted that adipogenesis involves two sequential steps: commitment of mesenchymal stem
cells (MSCs) into APCs, acquiring the adipogenic potential and restricting them to the adipocyte linage,
followed by terminal adipocyte differentiation [13]. In the first step APCs begin to express CD34, a cell
surface antigen that distinguishes between adipogenic and non-adipogenic cell subpopulations [31].
This CD34+ cell subpopulation expresses almost exclusively the transcriptional factor Zfp423 [32],
which in turn activates the basal expression of PPAR-γ2, a key pro-adipogenic signal that assures APCs
conversion into adipocytes [33]. The differential expression of both transcriptional factors determines
the competency of APCs, in other words, a cell’s ability to differentiate into adipocytes upon the action
of adipogenic stimulus [13]. Finally, in response to the adipogenic stimulus, APCs differentiate into
mature adipocytes, cells mainly characterized by intracellular lipid storage and insulin responsiveness.
We were able to assess how the eight-week FRD intake affects competency of APCs from RPAT
pads. For this purpose we evaluated the mRNA expression levels of PPARγ2 and Zfp423 in freshly
isolated SVF cells. We found that APCs from FRD rats showed an increase in both competency markers,
which have also been found after shorter periods of high fructose intake [15], indicating that high APCs
competency is maintained between three and eight weeks of FRD intake. This phenomenon might be
responsible for the small new adipocyte population observed in FRD rats, as discussed above. FRD
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intake also induced an increase in APCs MR gene expression without any change in that of GR, both
receptors being natural mediators of the pro-adipogenic effects of glucocorticoids [34,35]. However,
FRD intake did not modify APCs expression of two anti-adipogenic factors Pref-1 and Wnt10b, thus
suggesting that the main FRD effect could be due to the change in APCs competency.
The cell expression pattern of both competency and pro-adipogenic factors in FRD-fed rats reveals
an increased APC ability to differentiate into mature adipocytes. Indeed, FRD differentiated adipocytes
also showed higher lipid intracellular content, differentiation percentage and expression levels of
C/EBPα, Ob and IRS-1/-2 than CTR adipocytes. Collectively, these results indicate that APCs from
FRD rats have a greater ability to become mature adipocytes. It is reasonable to speculate that some
of the alterations observed in FRD APCs could be due to, in some degree , a direct fructose effect
on these cells; in fact, after intestinal absorption a percentage of fructose enters into the systemic
circulation and is metabolized by extrahepatic tissues, such as the AT [36]. Both 3T3-L1 preadipocytes
and adipocytes express the specific fructose transporter GLUT-5 [17,37]. It has been described that
GLUT-5 gene expression is higher in undifferentiated than differentiated 3T3-L1 cells [17], in which
it is practically undetectable [17,38], thus indicating that adipocyte precursors are a better target for
fructose action than mature adipocytes. Our results showed that cell GLUT-5 expression was not
modified by either FRD intake (in vivo experiments) or direct fructose treatment (in vitro experiments).
These results correspond with other reports describing that GLUT-5 is not modulated by an increase in
substrate supply [39,40]. However, other authors have shown the opposite [18]. On the other hand, as
previously reported [17], we found that GLUT-5 gene expression in both fresh SVF cells and cultured
APCs, was greater than that of GLUT-4. Further studies are needed to evaluate any effect on other
glucose transporters, such as GLUT-10 and GLUT-12, which are also expressed in adipocytes and
SVF cells [41]. There are few available reports regarding direct fructose effects on adipogenesis that
have only focused on the terminal differentiation stage of 3T3-L1 preadipocytes [17]. The presence
of fructose (55–5500 µM) during adipocyte differentiation induced an increase in PPARγ2, C/EBPα
among other pro-adipogenic factors, and either GLUT-5 knockdown or overexpression reduced or
increased this effect, respectively [17]. GLUT-5´/´ mice have diminished EAT mass compared with
wild-type mice, and mouse embryonic fibroblasts derived from GLUT-5´/´ mice exhibited impaired
adipocyte differentiation [17]. Also, fructose in the culture medium increased lipolysis and the activity
of 11-β hydroxysteroid dehydrogenase-1 in differentiated 3T3-L1 cells [18]. To our knowledge, the
present work is the first that evaluates direct fructose effects on the early stages of adipogenesis;
i.e., before inducing cell differentiation. To this purpose, APCs were grown in presence of FRU for
seven days. In this condition APCs expressed higher mRNA levels of PPARγ2 without any change in
Zfp423, indicating a greater APCs competency. A similar result was found when cells were cultured
with a comparable concentration of GLU. As found in the APCs from FRD rats, FRU did not modify
the gene expression of Pref-1 and WNT10b. It has been proposed that the balance between MR/GR
plays a key role in the pro-adipogenic effects of glucocorticoids. We found that the APCs grown in the
presence of FRU had higher MR and lower GR mRNA levels. Interestingly, no GLU effect on cell MR
expression was found. In agreement with this data, it has been described that fructose decreases GR
gene expression in adipocytes [42]. Interestingly, when the FRU-exposed APCs were differentiated
they accumulated high lipid content. Taken together, these in vitro results are quite similar to those we
observed in freshly isolated SVF cells from FRD rats.
Another factor that can influence the adipogenic potential in each AT depot is its APCs number.
It is generally accepted that subcutaneous AT contains more APCs than AAT [43]. High fat diet intake
increases the number of APCs in different AT depots [43,44]. Interestingly, we have previously reported
that three-week FRD intake does not induce any change in the number of APCs in RPAT [15]. However,
in the present study we evaluated whether a longer period of FRD intake (eight weeks) might alter
RPAT APCs number, quantified by using the CD34+CD31´CD45´ FACS pattern [15]. Our results
showed an increase in the number of APCs present in RPAT SVF cells from FRD rats. This fact, together
with their higher APC competency, clearly indicates a greater differentiation capacity of the RPAT from
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FRD rats. Additionally, we evaluated the direct effect of fructose on APCs number. Our results showed
that FRU directly induced an increase in both CD34+CD31´ cell number and percentage. However,
these results were not observed by using GLU, thus indicating a fructose-specific effect.
5. Conclusions
The present study demonstrates that long-term FRD intake altered the RPAT APCs by enhancing
their adipogenic potential. Indeed, eight weeks of FRD intake were able to modulate APCs competency
and number. Although we previously reported that three weeks of FRD intake modified APCs
competency [15], the effect of FRD on APCs number is a novel observation. Moreover and importantly,
it has now been assessed that FRU directly modulates the adipogenic competency and number of APCs.
In addition, it is important to highlight that the fructose-induced changes in the number/competency
of the APCs were not observed with glucose, which agree with the highest GLUT-5 compared with
GLUT-4 expression levels in the APCs. It is more than likely that, after both direct and indirect fructose
effects, APCs are more capable of generating new adipocytes, which subsequently and as a result of the
positive energy balance, will become hypertrophic and contribute to an unhealthy AT mass expansion.
In conclusion, although we demonstrated that fructose intake can activate the adipogenic
process in the RPAT, overall the activation of the hyperplasia would not be enough to counteract the
hypertrophy. Therefore, predominant hypertrophic RPAT expansion could lead to the development
of adiposity dysfunctions, and consequently to the endocrine-metabolic alterations also seen in the
human metabolic syndrome/obese phenotype.
Acknowledgments: This work was supported by grants from CONICET (PIP-2013-2015-0198), FONCYT
(PICT-2012-1415 and PICT-2013-0930) and FPREDM (062013). Authors are grateful to Rebecca Doyle for careful
manuscript edition/correction. A.A., G.M., E.S. and A.G. are researchers from the National Research Council of
Argentina (CONICET).
Author Contributions: A.G., M.G.Z. and E.S. conceived and designed the experiments. M.G.Z. performed
research. A.A. and M.A.R. participated in cell culture and qPCR assays and analyses. G.M. participated in FACS
experiments and analyses. A.G. and M.G.Z. analyzed all data and wrote the manuscript. E.S. participated in the
critical revision and correction of the final manuscript. All authors read and approved the final manuscript.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. Malik, V.S.; Popkin, B.M.; Bray, G.A.; Després, J.-P.; Willett, W.C.; Hu, F.B. Sugar-sweetened beverages
and risk of metabolic syndrome and type 2 diabetes: A meta-analysis. Diabetes Care 2010, 33, 2477–2483.
[CrossRef] [PubMed]
2. Høstmark, A.T. The Oslo health study: Soft drink intake is associated with the metabolic syndrome.
Appl. Physiol. Nutr. Metab. 2010, 35, 635–642. [CrossRef] [PubMed]
3. Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.-H.; Gersch, M.S.; Benner, S.;
Sánchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the
metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86,
899–906. [PubMed]
4. Tappy, L.; Lê, K.A.; Tran, C.; Paquot, N. Fructose and metabolic diseases: New findings, new questions.
Nutrition 2010, 26, 1044–1049. [CrossRef] [PubMed]
5. Parks, E.J.; Skokan, L.E.; Timlin, M.T.; Dingfelder, C.S. Dietary sugars stimulate fatty acid synthesis in adults.
J. Nutr. 2008, 138, 1039–1046. [PubMed]
6. Samuel, V.T. Fructose induced lipogenesis: From sugar to fat to insulin resistance. Trends Endocrinol. Metab.
2011, 22, 60–65. [CrossRef] [PubMed]
7. Douard, V.; Ferraris, R.P. Regulation of the fructose transporter GLUT5 in health and disease. Am. J. Physiol.
Endocrinol. Metab. 2008, 295, E227–E237. [CrossRef] [PubMed]
8. Litherland, G.J.; Hajduch, E.; Gould, G.W.; Hundal, H.S. Fructose transport and metabolism in adipose tissue
of Zucker rats: Diminished GLUT5 activity during obesity and insulin resistance. Mol. Cell. Biochem. 2004,
261, 23–33. [CrossRef] [PubMed]
Nutrients 2016, 8, 198 14 of 15
9. Björkman, O.; Felig, P. Role of the kidney in the metabolism of fructose in 60-hour fasted humans. Diabetes
1982, 31, 516–520. [CrossRef] [PubMed]
10. Skurk, T.; Alberti-Huber, C.; Herder, C.; Hauner, H. Relationship between adipocyte size and adipokine
expression and secretion. J. Clin. Endocrinol. Metab. 2007, 92, 1023–1033. [CrossRef] [PubMed]
11. Franck, N.; Stenkula, K.G.; Ost, A.; Lindström, T.; Strålfors, P.; Nystrom, F.H. Insulin-induced GLUT4
translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated
from the same individual. Diabetologia 2007, 50, 1716–1722. [CrossRef] [PubMed]
12. Wåhlen, K.; Sjölin, E.; Löfgren, P. Role of fat cell size for plasma leptin in a large population based sample.
Exp. Clin. Endocrinol. Diabetes 2011, 119, 291–294. [CrossRef] [PubMed]
13. Cristancho, A.G.; Lazar, M.A. Forming functional fat: A growing understanding of adipocyte differentiation.
Nat. Rev. Mol. Cell Biol. 2011, 12, 722–734. [CrossRef] [PubMed]
14. Alzamendi, A.; Giovambattista, A.; Raschia, A.; Madrid, V.; Gaillard, R.C.; Rebolledo, O.; Gagliardino, J.J.;
Spinedi, E. Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats.
Endocrine 2009, 35, 227–232. [CrossRef] [PubMed]
15. Zubiría, M.G.; Fariña, J.P.; Moreno, G.; Gagliardino, J.J.; Spinedi, E.; Giovambattista, A. Excess fructose
intake-induced hypertrophic visceral adipose tissue results from unbalanced precursor cell adipogenic
signals. FEBS J. 2013, 280, 5864–5874. [CrossRef] [PubMed]
16. Fariña, J.P.; García, M.E.; Alzamendi, A.; Giovambattista, A.; Marra, C.A.; Spinedi, E.; Gagliardino, J.J.
Antioxidant treatment prevents the development of fructose-induced abdominal adipose tissue dysfunction.
Clin. Sci. 2013, 125, 87–97. [CrossRef] [PubMed]
17. Du, L.; Heaney, A.P. Regulation of adipose differentiation by fructose and GluT5. Mol. Endocrinol. 2012, 26,
1773–1782. [CrossRef] [PubMed]
18. Legeza, B.; Balázs, Z.; Odermatt, A. Fructose promotes the differentiation of 3T3-L1 adipocytes and
accelerates lipid metabolism. FEBS Lett. 2014, 588, 490–496. [CrossRef] [PubMed]
19. Perelló, M.; Gaillard, R.C.; Chisari, A.; Spinedi, E. Adrenal enucleation in MSG-damaged hyperleptinemic
male rats transiently restores adrenal sensitivity to leptin. Neuroendocrinology 2003, 78, 176–184. [PubMed]
20. Giovambattista, A.; Gaillard, R.C.; Spinedi, E. Ghrelin gene-related peptides modulate rat white adiposity.
Vitam. Horm. 2008, 77, 171–205. [PubMed]
21. Tchoukalova, Y.D.; Harteneck, D.A.; Karwoski, R.A.; Tarara, J.; Jensen, M.D. A quick, reliable, and automated
method for fat cell sizing. J. Lipid Res. 2003, 44, 1795–1801. [CrossRef] [PubMed]
22. Maumus, M.; Sengenès, C.; Decaunes, P.; Zakaroff-Girard, A.; Bourlier, V.; Lafontan, M.; Galitzky, J.;
Bouloumié, A. Evidence of in situ proliferation of adult adipose tissue-derived progenitor cells: Influence of
fat mass microenvironment and growth. J. Clin. Endocrinol. Metab. 2008, 93, 4098–4106. [CrossRef] [PubMed]
23. Giovambattista, A.; Piermaría, J.; Suescun, M.O.; Calandra, R.S.; Gaillard, R.C.; Spinedi, E. Direct effect of
ghrelin on leptin production by cultured rat white adipocytes. Obesity 2006, 14, 19–27. [CrossRef] [PubMed]
24. Chen, J.; Dodson, M.V.; Jiang, Z. Cellular and molecular comparison of redifferentiation of intramuscular-
and visceral-adipocyte derived progeny cells. Int. J. Biol. Sci. 2010, 6, 80–88. [CrossRef] [PubMed]
25. Grégoire, F.; Todoroff, G.; Hauser, N.; Remacle, C. The stroma-vascular fraction of rat inguinal and epididymal
adipose tissue and the adipoconversion of fat cell precursors in primary culture. Biol. Cell Auspices Eur. Cell
Biol. Organ. 1990, 69, 215–222.
26. Alzamendi, A.; Giovambattista, A.; García, M.E.; Rebolledo, O.R.; Gagliardino, J.J.; Spinedi, E. Effect of
pioglitazone on the fructose-induced abdominal adipose tissue dysfunction. PPAR Res. 2012, 2012, 259093.
[CrossRef] [PubMed]
27. Lowette, K.; Roosen, L.; Tack, J.; Vanden Berghe, P. Effects of high-fructose diets on central appetite signaling
and cognitive function. Front. Nutr. 2015, 2, 5. [CrossRef] [PubMed]
28. Lindqvist, A.; Baelemans, A.; Erlanson-Albertsson, C. Effects of sucrose, glucose and fructose on peripheral
and central appetite signals. Regul. Pept. 2008, 150, 26–32. [CrossRef] [PubMed]
29. Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.;
Dyachenko, A.; Zhang, W.; et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases
visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig.
2009, 119, 1322–1334. [CrossRef] [PubMed]
30. Crescenzo, R.; Bianco, F.; Coppola, P.; Mazzoli, A.; Valiante, S.; Liverini, G.; Iossa, S. Adipose tissue
remodeling in rats exhibiting fructose-induced obesity. Eur. J. Nutr. 2014, 53, 413–419. [CrossRef] [PubMed]
Nutrients 2016, 8, 198 15 of 15
31. Sengenès, C.; Lolmède, K.; Zakaroff-Girard, A.; Busse, R.; Bouloumié, A. Preadipocytes in the human
subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem
cells. J. Cell. Physiol. 2005, 205, 114–122. [CrossRef] [PubMed]
32. Gupta, R.K.; Arany, Z.; Seale, P.; Mepani, R.J.; Ye, L.; Conroe, H.M.; Roby, Y.A.; Kulaga, H.; Reed, R.R.;
Spiegelman, B.M. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010, 464, 619–623.
[CrossRef] [PubMed]
33. Tontonoz, P.; Spiegelman, B.M. Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem.
2008, 77, 289–312. [CrossRef] [PubMed]
34. Caprio, M.; Fève, B.; Claës, A.; Viengchareun, S.; Lombès, M.; Zennaro, M.-C. Pivotal role of the
mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J. 2007, 21, 2185–2194. [CrossRef]
[PubMed]
35. Lee, M.-J.; Fried, S.K. The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role
in adipogenesis and adipokine production in human adipocytes. Int. J. Obes. 2014, 38, 1228–1233. [CrossRef]
[PubMed]
36. Bray, G.A. How bad is fructose? Am. J. Clin. Nutr. 2007, 86, 895–896. [PubMed]
37. Hajduch, E.; Darakhshan, F.; Hundal, H.S. Fructose uptake in rat adipocytes: GLUT5 expression and the
effects of streptozotocin-induced diabetes. Diabetologia 1998, 41, 821–828. [CrossRef] [PubMed]
38. Romero, M.; del, M.; Sabater, D.; Fernández-López, J.A.; Remesar, X.; Alemany, M. Glycerol Production
from Glucose and Fructose by 3T3-L1 Cells: A Mechanism of Adipocyte Defense from Excess Substrate.
PLoS ONE 2015, 10, e0139502. [CrossRef] [PubMed]
39. Darakhshan, F.; Hajduch, E.; Kristiansen, S.; Richter, E.A.; Hundal, H.S. Biochemical and functional
characterization of the GLUT5 fructose transporter in rat skeletal muscle. Biochem. J. 1998, 336, 361–366.
[CrossRef] [PubMed]
40. Robubi, A.; Huber, K.R.; Krugluger, W. Extra fructose in the growth medium fuels lipogenesis of adipocytes.
J. Obes. 2014, 2014, 647034. [CrossRef] [PubMed]
41. Wood, I.S.; Hunter, L.; Trayhurn, P. Expression of Class III facilitative glucose transporter genes (GLUT-10
and GLUT-12) in mouse and human adipose tissues. Biochem. Biophys. Res. Commun. 2003, 308, 43–49.
[CrossRef]
42. Kovacˇevic´, S.; Nestorov, J.; Matic´, G.; Elakovic´, I. Dietary fructose-related adiposity and glucocorticoid
receptor function in visceral adipose tissue of female rats. Eur. J. Nutr. 2014, 53, 1409–1420. [CrossRef]
[PubMed]
43. Joe, A.W.B.; Yi, L.; Even, Y.; Vogl, A.W.; Rossi, F.M. V Depot-specific differences in adipogenic progenitor
abundance and proliferative response to high-fat diet. Stem Cells 2009, 27, 2563–2570. [CrossRef] [PubMed]
44. Macotela, Y.; Emanuelli, B.; Mori, M.A.; Gesta, S.; Schulz, T.J.; Tseng, Y.-H.; Kahn, C.R. Intrinsic Differences
in Adipocyte Precursor Cells From Different White Fat Depots. Diabetes 2012, 61, 1691–1699. [CrossRef]
[PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons by Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
